Page 31 | Certara

On-Demand Webinar

Unlock Global Regulatory Success: Overcoming Early Drug Development Challenges [APAC Webinar]

Navigating early drug development is critical to ensuring the long-term success of therapeutic candidates. This…

CertaraJanuary 10, 2025

Blog

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters

January 10, 2025 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A…

CertaraJanuary 10, 2025

Announcement

Certara Appoints New Head of Biometrics, Data Science, and Access

January 10, 2025 RADNOR, PA. – January 10, 2025 – Certara, Inc. (Nasdaq: CERT), a global…

CertaraJanuary 10, 2025

On-Demand Webinar

Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA)

In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive…

CertaraJanuary 9, 2025

Publication

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…

CertaraJanuary 8, 2025

Case Study

Helping Sponsor Meet EMA Policy 0070 Requirements

The European Medicines Agency’s Policy on the Publication of Clinical Data for Medicinal Products for…

CertaraJanuary 7, 2025

On-Demand Webinar

AI-powered regulatory writing software – Frequently asked questions by Japanese customers [Japanese Webinar]

Faced with more and more complex clinical research than ever before, regulatory writers are facing…

CertaraJanuary 6, 2025

On-Demand Webinar

Where to Start? Setting Your Medical Writing Team Up for Success with GenAI

Generative AI (GenAI) is poised to revolutionize writing and report generation. In fact, industry studies…

CertaraJanuary 6, 2025

On-Demand Webinar

Optimizing DDI Knowledge throughout Drug Development

Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…

CertaraJanuary 6, 2025

Press Coverage

Pharma – 2025 Health IT Predictions

Discover transformative 2025 Health IT predictions, from AI in drug discovery to personalized medicine and…

CertaraJanuary 3, 2025

Unlock Global Regulatory Success: Overcoming Early Drug Development Challenges [APAC Webinar]

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters

Certara Appoints New Head of Biometrics, Data Science, and Access

Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA)

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

Helping Sponsor Meet EMA Policy 0070 Requirements

AI-powered regulatory writing software – Frequently asked questions by Japanese customers [Japanese Webinar]

Where to Start? Setting Your Medical Writing Team Up for Success with GenAI

Optimizing DDI Knowledge throughout Drug Development

Pharma – 2025 Health IT Predictions

Newsletter sign up

Quick links

Solutions

Contact